SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending due to widespread anticipation surrounding the outcome of a recent FDA meeting concerning its lead drug, Sonelokimab, for Hidradenitis Suppurativa. The community largely expects a positive regulatory update, which many believe would significantly de-risk the asset. This has intensified discussions about a potential acquisition by a major pharmaceutical player, fueled by reported prior interest and recent executive share conversions interpreted by some as preparatory for a substantial transaction.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending due to anticipation surrounding its showcase of commercial quantum computing solutions and real-world applications at an upcoming major tech event, fueling speculation about its "quantum supremacy" in optimization. The community is actively debating its potential as a generational technology, drawing comparisons to early AI, while skeptics point to its current low revenue, cash burn, and perceived overvaluation amidst allegations of manipulated "pump and dump" cycles.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending amid strong community buzz surrounding its upcoming merger with Infleqtion, a quantum technology leader. Investors are highlighting Infleqtion's established partnerships with defense and aerospace entities, along with its commercially viable quantum sensing and timing solutions, which many believe are significantly undervalued compared to sector peers. The sentiment suggests anticipation for substantial institutional investment and accelerated growth once the ticker changes post-merger.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is experiencing extreme volatility following its recent IPO, igniting intense community debate. Bulls highlight its low float and aerospace sector exposure as potential catalysts for a massive squeeze, while skeptics label it a pump-and-dump, raising concerns about its valuation, pre-revenue status, and the qualifications of its R&D team. The stock's dramatic price swings and unusually high short borrow fees are central to the ongoing, heated discussion.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is generating intense buzz ahead of its highly anticipated BlueBird 6 satellite launch, which is viewed as a pivotal moment for its space-based cellular network deployment. The community is sharply divided, with fervent bulls anticipating substantial gains post-launch, while bears warn of an overvalued stock and a potential "sell the news" event. This dichotomy is fueling significant conversation and market volatility around the company's future in satellite communications.

TOSHI

TOSHI is a trending topic, with its community deeply engaged in discussions around its role as the "Face of Base" blockchain following recent listings on major exchanges and a Coinbase One collaboration. Despite recent market volatility, the "blue cat" faithful are actively accumulating, anticipating future growth and potential listings on platforms like Robinhood or Binance, highlighting strong long-term conviction.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending with intense anticipation surrounding a pivotal FDA decision for its drug Narsoplimab (Yartemlea) by December 26th, targeting a life-threatening condition without an approved treatment. This binary event is bolstered by the recent closing of a significant deal with Novo Nordisk, bringing in substantial upfront cash and potential future milestones, along with a $100 million share repurchase program, fueling community expectations for a transformative approval and a notable short squeeze.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is a trending topic, actively debated by the community, driven by its pivotal role in US LNG exports and strategic moves in a shifting global energy landscape. Bulls see it as deeply undervalued with strong operational performance and significant long-term growth potential, fueled by Europe's pivot from Russian gas and recent competitive developments. However, ongoing arbitration cases and recent analyst downgrades continue to generate concern and mixed sentiment regarding near-term price action.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is seeing a historic surge to new all-time highs, driven by significant global supply tightening, notably China's impending silver export restrictions, and accelerating industrial demand from AI data centers, EVs, and solar sectors. The community is actively discussing a potential parabolic "silver squeeze" and a major re-rating of its value, despite some warnings of an extremely overbought market and an anticipated near-term pullback.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as gold prices reach new all-time highs, fueled by geopolitical concerns and growing anticipation of significant central bank liquidity injections and rate cuts. Community chatter highlights a divergence in sentiment, with many celebrating gold's role as a critical safe haven and hedge against fiat debasement, while others warn of a speculative bubble and an imminent "violent correction." This rise is widely interpreted as a signal of deep macroeconomic uncertainty, with discussions often framing it as a "currency reset" and a rotation into tangible assets amid global debt concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Congress Asset Management Co. Lowers Stake in Vericel Corporation $VCEL

Congress Asset Management Co. cut its position in Vericel Corporation (NASDAQ:VCEL - Free Report) by 14.2% in the third quarter, according to the company in its most recent disclosure with the...

Osterweis Capital Management Inc. Takes $9.71 Million Position in Vericel Corporation $VCEL

Osterweis Capital Management Inc. bought a new stake in Vericel Corporation (NASDAQ:VCEL - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and...

Frontier Capital Management Co. LLC Raises Holdings in Vericel Corporation $VCEL

Frontier Capital Management Co. LLC increased its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 74.3% in the second quarter, according to its most recent disclosure with the...

Next Century Growth Investors LLC Has $28.45 Million Stock Position in Vericel Corporation $VCEL

Next Century Growth Investors LLC lifted its stake in shares of Vericel Corporation (NASDAQ:VCEL - Free Report) by 14.8% during the second quarter, according to the company in its most recent Form...

Vericel Corporation $VCEL Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. lessened its position in Vericel Corporation (NASDAQ:VCEL - Free Report) by 15.7% during the 2nd quarter, according to the company in its most recent disclosure with the...

Russell Investments Group Ltd. Purchases 32,976 Shares of Vericel Corporation $VCEL

Russell Investments Group Ltd. boosted its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 38.4% in the second quarter, according to its most recent filing with the SEC. The...

Vericel Corporation $VCEL is Brown Capital Management LLC's 9th Largest Position

Brown Capital Management LLC decreased its stake in shares of Vericel Corporation (NASDAQ:VCEL - Free Report) by 2.4% during the second quarter, according to its most recent filing with the...

New York State Common Retirement Fund Increases Position in Vericel Corporation $VCEL

New York State Common Retirement Fund increased its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 3.3% in the second quarter, according to its most recent filing with the Securities...

Vericel Corporation $VCEL Shares Sold by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P trimmed its holdings in Vericel Corporation (NASDAQ:VCEL - Free Report) by 2.4% during the second quarter, according to the company in its most recent filing with the...

Vericel Corporation (NASDAQ:VCEL) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Vericel Corporation (NASDAQ:VCEL - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven analysts that are presently covering the stock, MarketBeat...

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Current Price	$37.38
Prev Close	$37.37
Open	$37.41
Dividend Yield	0.00%
50-Day Moving Average	$37.43
Beta	1.23
Avg. Volume	698,916.79
PE Ratio	155.23

52-Week High	$63.00
52-Week Low	$29.24
Market Capitalization	$1.89B
EPS (Annual)	$0.2005
Price to Book	5.87
Revenue Per Employee	$664,493.00
Enterprise Value/EBITDA	N/A

VCEL
Vericel Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VCEL News

VCELVericel Corp